Last reviewed · How we verify
NCT06129877
CHAMP App Feeding Difficulties Repository
trial testing CHAMP App in Feeding and Eating Disorders of Childhood in 1,000 participants. Enrolling by invitation.
31 December 2028
Quick facts
| Lead sponsor | Children's Mercy Hospital Kansas City |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 9 November 2023 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 December 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CHAMP App
Conditions studied
- Feeding and Eating Disorders of Childhood — all drugs for Feeding and Eating Disorders of Childhood →
- Gastrostomy — all drugs for Gastrostomy →
- Feeding Disorder of Infancy and Childhood — all drugs for Feeding Disorder of Infancy and Childhood →
Sponsor
Children's Mercy Hospital Kansas City
Who can join
Adults 1 Month to 18, any sex, with Feeding and Eating Disorders of Childhood or Gastrostomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This repository will consist of home monitoring data, videos, and images of patients with feeding difficulties for asynchronous remote patient monitoring of manually entered data sent by parents to the healthcare team using the CHAMP App for children with feeding difficulties. This information will be collected under a research protocol and this repository is for future research applications.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06129877
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CHAMP App
Trials testing the same drug.
- NCT06034392 — CHAMP App Cardiac Study and Repository · enrolling by invitation
Other recruiting trials for Feeding and Eating Disorders of Childhood
Currently open trials in the same condition.
- NCT07153549 — Biolizin for Improving Functional Poor Appetite in Children Aged 6 to 36 Months (CTBE2502) · NA · recruiting
Other Children's Mercy Hospital Kansas City trials
Trials by the same sponsor.
- NCT07458568 — ViBandz Feasibility Study · not yet recruiting
- NCT07195032 — Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients · Phase 4 · recruiting
- NCT06834594 — Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome · Phase 4 · recruiting
- NCT06738121 — Cosmetic Outcomes of Umbilical Hernia Incisions · NA · completed
- NCT06520657 — Addressing Social Determinants of Health in Child Obesity Treatment Using Community Health Workers · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06129877 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Mercy Hospital Kansas City
- Last refreshed: 4 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06129877.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing